Report
Novo's experimental CagriSema shows 25% weight loss in women in late-stage analysis
CNBC reports Novo released new evidence suggesting its experimental CagriSema injection could improve on weight loss with Wegovy.
TLDR
CNBC reports that a late-stage analysis of Novo's experimental CagriSema injection showed 25% weight loss in women. The new evidence suggests it could improve on the weight loss with Novo's GLP-1 obesity injection, Wegovy.
Combined views
11.3K
1 Source, first seen ago